<DOC>
	<DOCNO>NCT00004984</DOCNO>
	<brief_summary>The Diabetes Prevention Trial Type 1 ( DPT-1 ) multicenter randomize , control clinical trial design determine whether possible delay prevent clinical onset type 1 diabetes daily dos insulin individual determine risk disease . The parenteral insulin trial DPT-1 complete , however , oral insulin trial still recruit . Over 350 site United States , Canada , Puerto Rico take part study . Screening patient ongoing ; approximately 100,000 nondiabetic relative person type 1 diabetes screen detect presence islet cell antibody . Those individual find islet cell antibody stag determine risk diabetes base genetic , immunologic , metabolic characteristic . Those individual find intermediate risk diabetes randomize receive insulin orally receive placebo . Patients follow six year .</brief_summary>
	<brief_title>The Diabetes Prevention Trial Type 1 Diabetes ( DPT-1 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Individuals 345 year old immediate family member type 1 diabetes ( child , parent , sibling ) Individuals 320 year old extend family member type 1 diabetes ( cousin , niece , nephew , aunt , uncle , grandparent , halfsibling ) To eligible , person must : Not diabetes already . Have previous history treat insulin oral diabetes medication . Have receive prior therapy prevention type 1 diabetes insulin , nicotinamide , immunosuppressive drug ( i.e . involve previous clinical study agent . ) Have know serious disease . If woman , must plan become pregnant course study . You exclude participation , encourage volunteer first place plan baby trial period ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin</keyword>
	<keyword>prediction</keyword>
	<keyword>prevention</keyword>
	<keyword>C-peptide level</keyword>
	<keyword>insulin autoantibody</keyword>
	<keyword>pancreatic beta cell autoantibody</keyword>
	<keyword>cellular immune response</keyword>
	<keyword>prediction type 1 diabetes</keyword>
</DOC>